GLMD - Galmed Pharmaceuticals Ltd logo

GLMD

Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals develops therapeutics for liver diseases, focusing on Aramchol, an oral treatment for non-alcoholic steatohepatitis (NASH). The company conducts clinical trials for various liver-related conditions and collaborates on commercialization efforts.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$1today

Score Overview

1 Year
Scoreโ€”
Net Growth-36.03%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth56.81%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Score
Net Growth17.28%
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-54.05%
Net Trend33%
Net Income Consistency
Rev Growthโ€”
Rev Trend25%
Revenue Consistency

See the full market ranking โ†’

Galmed Pharmaceuticals Ltd fundamental performance

Between 2015 and 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 10M to -$ 10M. Revenue increased in 2 of those 10 years; net income in 4.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.56โ€”
1 Year2025-08-12
$ 1.42-60.56%
5 Years2021-08-12
$ 538.20-99.90%
10 Years2016-08-12
$ 730.80-99.92%
All Time2014-03-13
$ 2.58K-99.98%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 14M$ 18M
2025$ 0.00-$ 10M$ 18M
2024$ 0.00-$ 7M$ 15M
2023$ 0.00-$ 6M$ 12M
2022$ 0.00-$ 17M$ 13M
2021$ 0.00-$ 32M$ 34M
2020$ 0.00-$ 28M$ 50M
2019$ 0.00-$ 20M$ 75M
2018$ 2M-$ 9M$ 90M
2017$ 1M-$ 12M$ 18M
2016$ 467K-$ 16M$ 15M
2015$ 0.00-$ 10M$ 23M
IPO2014$ 0.00-$ 9M$ 31M

Explore beyond GLMD

You're looking at Galmed Pharmaceuticals Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies